Nova Biomedical fait progresser les flux de travaux intégrés de développement de lignées cellulaires : les produits NanoCellect font maintenant partie de Nova Biomedical

Positive

AI Analysis

Summary

Nova Biomedical acquires certain assets of NanoCellect, a microfluidic cell sorting technology provider, to expand its cell line development capabilities. The transaction enhances Nova Biomedical's integrated workflow offerings for cell development.

Importance:5/10

Sentiment:

0.50

acquisitioncell line developmentmicrofluidic technologycell sorting

Read the original article

Published by PR Newswire Biotech on July 25, 2026 12:05 AM

Read Original